**There are many causes of recession. For some patients it can be caused by periodontal disease.
Stannous Fluoride starts working immediately* to relieve sensitivity pain within days.
Kills plaque bacteria that can lead to gingivitis, then potentially periodontitis- a cause of gingival recession**
Occludes exposed tubules to provide relief from sensitivity
Creates a layer of protection to shield exposed dentin.
Dentinal hypersensitivity is a common dental problem that is frequently encountered yet it is often under-reported by patients, or misdiagnosed by clinicians.This course will address the etiology, prevalence and diagnosis of dentinal hypersensitivity as well as review clinical evidence behind common treatments.
This course is a review and update of cosmetic and therapeutic dentifrices, their impact on market shares and the development of multi-benefit dentifrice technologies.
The purpose of Re-examining the Plaque-Gingivitis Connection and the Role of Stannous Fluoride is to review the role of plaque in the initiation of periodontal disease, share novel insights on the mechanism by which stannous fluoride reduces plaque-induced gingivitis, and discuss practical implications for dental professionals.
Crest Gum & Sensitivity dentifrice with stabilized stannous fluoride showed significantly greater tactile sensitivity relief — demonstrated by greater tolerance to a tactile stimulus — compared to a sodium fluoride negative control dentifrice.
In Fluoride Uptake testing, Crest Gum and Sensitivity dentifrice with bioavailable stannous fluoride (SnF2) fluoridated demineralized dentin lesions as well as the positive control and significantly better than the negative control.
Dentinal hypersensitivity is a common complaint among dental patients. This trial demonstrates the desensitizing efficacy of a bioavailable stannous fluoride dentifrice relative to a sodium fluoride control dentifrice.
To evaluate the efficacy of a marketed bioavailable stannous fluoride (SnF2) dentifrice in reducing dentinal hypersensitivity as compared to a marketed control dentifrice over an eight-week period.